K. Mandragos

Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]

A. Kirkham, A. Karabinis, K. Mandragos, 2004, Critical care.

Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries : a randomised , controlled trial [ ISRCTN 50308308 ]

A. Kirkham, A. Karabinis, K. Mandragos, 2015 .

Volume and flow dependence of respiratory mechanics in mechanically ventilated COPD patients

P. Behrakis, K. Mandragos, Yotanna Dalavanga, 2003, Respiratory Physiology & Neurobiology.

Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins.

A. Armaganidis, Christos G Gogos, K. Mandragos, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]

K. Mandragos, D. Georgopoulos, G. Dimopoulos, 2005, Critical care.

Pefloxacin versus ceftazidime in the treatment of a variety of gram-negative-bacterial infections

K. Mandragos, H. Giamarellou, G. Perdikaris, 1989, Antimicrobial Agents and Chemotherapy.

Recombinant human erythropoietin therapy in critically ill patients : a dose-response study [ ISRCTN 48523317 ]

K. Mandragos, D. Georgopoulos, G. Dimopoulos, 2015 .

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]

K. Mandragos, D. Georgopoulos, G. Dimopoulos, 2005, Critical care.